Vis enkel innførsel

dc.contributor.authorBjerknes, Tale Litlere
dc.contributor.authorSteihaug, Ole Martin
dc.contributor.authorHaugen, Mette
dc.contributor.authorHjelland, Ina Elen
dc.contributor.authorVedeler, Christian Alexander
dc.date.accessioned2023-01-19T08:52:17Z
dc.date.available2023-01-19T08:52:17Z
dc.date.created2023-01-07T12:49:29Z
dc.date.issued2022
dc.identifier.issn1664-2295
dc.identifier.urihttps://hdl.handle.net/11250/3044477
dc.description.abstractEncephalitis due to antibodies targeting dipeptidyl-peptidase-like protein 6 (DPPX), a potassium channel subunit, is rare. The illness is typically characterized by a triad of weight loss, CNS hyperexcitability and cognitive symptoms, but recent reports suggest that the clinical picture may be more heterogeneous. Here, we describe the case of a 63-year-old female who was admitted to the hospital with severe extremity pain, which had been preceded by diarrhea and weight loss. She later developed cognitive changes, and her general condition rapidly deteriorated. Extensive workup did not reveal gastrointestinal illness or underlying malignancies. MRI of the brain was normal. Analyses of blood and cerebrospinal fluid showed normal cell counts but high titres of DPPX antibodies in blood and cerebrospinal fluid. The patient was treated with intravenous methylprednisolone followed by rituximab. At 1-year follow-up, she was without pain and had completely recovered. In this case, DPPX-associated autoimmune encephalitis was dominated by severe extremity pain, illustrating that sensory symptoms may be one of the main complaints in these patients. It is important for clinicians to be aware of the heterogeneous clinical picture in this serious condition, since correct diagnosis and treatment with immunosuppressants are associated with favorable prognosis.en_US
dc.language.isoengen_US
dc.publisherFrontiersen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleCase report: Pain in anti-DPPX encephalitisen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2022 The Author(s)en_US
dc.source.articlenumber1091688en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.3389/fneur.2022.1091688
dc.identifier.cristin2102425
dc.source.journalFrontiers in Neurologyen_US
dc.identifier.citationFrontiers in Neurology. 2022, 13, 1091688.en_US
dc.source.volume13en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal